US 10138271
Native and agonist CTL epitopes of the MUC1 tumor antigen
granted A61KA61K2039/585A61K2239/49
Quick answer
US patent 10138271 (Native and agonist CTL epitopes of the MUC1 tumor antigen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/585, A61K2239/49, A61K2239/54, A61K2239/59